Last $43.77 USD
Change Today +0.65 / 1.51%
Volume 2.1M
PKI On Other Exchanges
Symbol
Exchange
New York
Berlin
As of 8:04 PM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

perkinelmer inc (PKI) Snapshot

Open
$43.33
Previous Close
$43.12
Day High
$44.30
Day Low
$43.31
52 Week High
07/3/14 - $48.26
52 Week Low
10/15/14 - $38.96
Market Cap
4.9B
Average Volume 10 Days
1.2M
EPS TTM
$1.98
Shares Outstanding
113.0M
EX-Date
01/14/15
P/E TM
22.1x
Dividend
$0.28
Dividend Yield
0.64%
Current Stock Chart for PERKINELMER INC (PKI)

perkinelmer inc (PKI) Related Businessweek News

No Related Businessweek News Found

perkinelmer inc (PKI) Details

PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, research, environmental, industrial, and laboratory services markets worldwide. The company operates through two segments, Human Health and Environmental Health. The Human Health segment develops diagnostics, tools, and applications to help detect diseases earlier, and to accelerates the discovery and development of critical new therapies. This segment provides early detection for genetic disorders from pre-conception to early childhood, as well as offers digital x-ray flat panel detectors and infectious disease testing for the diagnostics market; and a suite of solutions, such as reagents, liquid handling, and detection and imaging technologies that enable researchers to improve the drug discovery process. Its research portfolio includes instrumentation for automation and detection solutions, in vitro and in vivo imaging and analysis hardware and software, and a portfolio of consumable products, including drug discovery and research reagents. The Environmental Health segment provides services and solutions to facilitate the creation of safer food and consumer products, secure surroundings, and efficient energy resources. This segment offers analytical technologies, solutions, and services that enable its customers to understand the health aspects of environment, including air, water, soil, and food; analytical instrumentation for the industrial market that comprise the chemical, petrochemical, lubricant, electronics, semiconductor, and quality assurance industries; and laboratory services. The company markets its products and services under various brands directly through its own sales force. Its customers include pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1931 and is headquartered in Waltham, Massachusetts.

7,409 Employees
Last Reported Date: 11/4/14
Founded in 1931

perkinelmer inc (PKI) Top Compensated Officers

Chairman, Chief Executive Officer, President ...
Total Annual Compensation: $978.3K
Chief Financial Officer and Senior Vice Presi...
Total Annual Compensation: $469.6K
Senior Vice President and President of Human ...
Total Annual Compensation: $341.0K
Senior Vice President, General Counsel and Se...
Total Annual Compensation: $394.6K
Compensation as of Fiscal Year 2013.

perkinelmer inc (PKI) Key Developments

OncoSec Medical Inc. Collaborates with PerkinElmer, Inc. and the University of California, Los Angeles to Evaluate Patient-Selection Biomarker in Immunotherapy

OncoSec Medical Inc. announced a collaboration with PerkinElmer Inc. and the University of California, Los Angeles to help researchers develop biomarker tests to evaluate a patient's immune response to cancer. This research supports the ongoing shift in oncology toward therapeutic strategies that stimulate the patient's own immune defense system to combat cancer. The approach uses PerkinElmer's new imaging-based staining methods to quantitatively evaluate CD8+ T cell density in tumor biopsies.

PerkinElmer Inc. Presents at 26th Annual Piper Jaffray Healthcare Conference, Dec-02-2014 11:30 AM

PerkinElmer Inc. Presents at 26th Annual Piper Jaffray Healthcare Conference, Dec-02-2014 11:30 AM. Venue: The New York Palace Hotel, 455 Madison Ave, New York, NY 10022, United States. Speakers: James Corbett, Senior Vice President and President of Human Health.

PerkinElmer Inc. Presents at Jefferies 2014 Global Healthcare Conference: London, Nov-19-2014 11:20 AM

PerkinElmer Inc. Presents at Jefferies 2014 Global Healthcare Conference: London, Nov-19-2014 11:20 AM. Venue: The Waldorf Hilton, Aldwych, London, United Kingdom. Speakers: Robert F. Friel, Chairman, Chief Executive Officer, President and Member of Finance Committee.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PKI:US $43.77 USD +0.65

PKI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Getinge AB kr174.10 SEK +1.30
QIAGEN NV €19.25 EUR +0.202
Sirona Dental Systems Inc $89.85 USD +1.32
STERIS Corp $66.64 USD +1.21
Teleflex Inc $117.55 USD +1.31
View Industry Companies
 

Industry Analysis

PKI

Industry Average

Valuation PKI Industry Range
Price/Earnings 25.3x
Price/Sales 2.2x
Price/Book 2.4x
Price/Cash Flow 25.5x
TEV/Sales 1.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PERKINELMER INC, please visit www.perkinelmer.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.